
Oragenics, Inc.
OGENHealthcare|Biotechnology|US
$0.35
+0.00 (+0.04%)
DCF Value
$1.56
Tangible Book / Share
$0.83
Cash / Share
$0.87
Next Earnings Report
Nov 16, 2026
EPS est. -$90.00
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Mar 19, 2026 (S-3/A). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum
Sep 16, 2026 · GlobeNewsWire
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update
Aug 28, 2026 · GlobeNewsWire
SEC Filings (60)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Sep 16, 2026 | 8-K | Material event | DocumentIndex |
| Aug 28, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 6, 2026 | 8-K | Material event | DocumentIndex |
| May 20, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 20, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 19, 2026 | 8-K | Material event | DocumentIndex |
| May 8, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| May 8, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 7, 2026 | 8-K | Material event | DocumentIndex |
| Apr 13, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 20, 2026 | EFFECT | DocumentIndex | |
| Mar 19, 2026 | S-3/A | Shelf registration | DocumentIndex |
| Mar 16, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 11, 2026 | 8-K | Material event | DocumentIndex |
| Jan 22, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jan 22, 2026 | 8-K | Material event | DocumentIndex |
| Jan 21, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jan 20, 2026 | 8-K | Material event | DocumentIndex |
| Dec 15, 2025 | 8-K | Material event | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Nov 7, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 21, 2025 | 8-K | Material event | DocumentIndex |
| Sep 2, 2025 | 8-K | Material event | DocumentIndex |
| Aug 26, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 11, 2025 | 8-K | Material event | DocumentIndex |
| Aug 8, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jul 2, 2025 | 8-K | Material event | DocumentIndex |
| Jul 2, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jul 2, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Jun 30, 2025 | EFFECT | DocumentIndex | |
| Jun 30, 2025 | S-1/A | IPO / offering registration | DocumentIndex |
| Jun 23, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| May 28, 2025 | 8-K | Material event | DocumentIndex |
| May 20, 2025 | 8-K | Material event | DocumentIndex |
| May 9, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 2, 2025 | 8-K | Material event | DocumentIndex |
| Apr 11, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 9, 2025 | 8-K | Material event | DocumentIndex |